Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 256

1.

Histopathological regression predicts treatment outcome in locally advanced esophagogastric adenocarcinoma.

Spoerl S, Novotny A, Al-Batran SE, Lordick F, Thuss-Patience P, Pauligk C, Haller B, Feith M, Lorenzen S.

Eur J Cancer. 2017 Dec 19;90:26-33. doi: 10.1016/j.ejca.2017.11.020. [Epub ahead of print]

PMID:
29272782
2.

Individual Susceptibility Analysis Using Patient-derived Slice Cultures of Colorectal Carcinoma.

Sönnichsen R, Hennig L, Blaschke V, Winter K, Körfer J, Hähnel S, Monecke A, Wittekind C, Jansen-Winkeln B, Thieme R, Gockel I, Grosser K, Weimann A, Kubick C, Wiechmann V, Aigner A, Bechmann I, Lordick F, Kallendrusch S.

Clin Colorectal Cancer. 2017 Nov 21. pii: S1533-0028(17)30255-4. doi: 10.1016/j.clcc.2017.11.002. [Epub ahead of print]

PMID:
29233603
3.

Changing paradigms in adjuvant treatment of colorectal cancer.

Lordick F.

Lancet Gastroenterol Hepatol. 2018 Jan;3(1):6-8. doi: 10.1016/S2468-1253(17)30332-1. Epub 2017 Oct 24. No abstract available.

PMID:
29079409
4.

PAXgene fixation enables comprehensive metabolomic and proteomic analyses of tissue specimens by MALDI MSI.

Urban C, Buck A, Siveke JT, Lordick F, Luber B, Walch A, Aichler M.

Biochim Biophys Acta. 2018 Jan;1862(1):51-60. doi: 10.1016/j.bbagen.2017.10.005. Epub 2017 Oct 9.

PMID:
29024724
5.

Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome.

Kunzke T, Balluff B, Feuchtinger A, Buck A, Langer R, Luber B, Lordick F, Zitzelsberger H, Aichler M, Walch A.

Oncotarget. 2017 Jul 10;8(40):68012-68025. doi: 10.18632/oncotarget.19137. eCollection 2017 Sep 15.

6.

Treatment of oesophageal cancer - Stressing the patient perspective.

Lordick F.

Eur J Cancer. 2017 Oct;84:360-362. doi: 10.1016/j.ejca.2017.08.021. No abstract available.

PMID:
28942866
7.

Will molecular target agents enable the multidisciplinary treatment in stage IV gastric cancer?

Kataoka K, Deleersnijder A, Lordick F.

Eur J Surg Oncol. 2017 Oct;43(10):1835-1845. doi: 10.1016/j.ejso.2017.08.006. Epub 2017 Aug 30. Review.

PMID:
28888797
8.

Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.

Segelov E, Lordick F, Goldstein D, Chantrill LA, Croagh D, Lawrence B, Arnold D, Chau I, Obermannova R, Price TJ.

Expert Rev Anticancer Ther. 2017 Oct;17(10):951-964. doi: 10.1080/14737140.2017.1369882. Epub 2017 Aug 28. Review.

PMID:
28817982
9.

Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.

Haag GM, Stocker G, Quidde J, Jaeger D, Lordick F.

BMC Cancer. 2017 Jul 31;17(1):509. doi: 10.1186/s12885-017-3497-9.

10.

Oesophageal cancer.

Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, Cunningham D.

Nat Rev Dis Primers. 2017 Jul 27;3:17048. doi: 10.1038/nrdp.2017.48. Review.

PMID:
28748917
11.

[Cancer Throughout the Lifespan - Addressing the Psychosocial Needs of Diverse Populations].

Mehnert A, Lordick F.

Psychother Psychosom Med Psychol. 2017 Jul;67(7):277-278. doi: 10.1055/s-0043-111733. Epub 2017 Jul 18. German.

PMID:
28719919
12.

Internet-based perioperative exercise program in patients with Barrett's carcinoma scheduled for esophagectomy [iPEP - study] a prospective randomized-controlled trial.

Pfirrmann D, Tug S, Brosteanu O, Mehdorn M, Busse M, Grimminger PP, Lordick F, Glatz T, Hoeppner J, Lang H, Simon P, Gockel I.

BMC Cancer. 2017 Jun 14;17(1):413. doi: 10.1186/s12885-017-3400-8.

13.

Oligometastases of Gastrointestinal Cancer Origin.

Klar E, Büchler MW, Lang H, Lordick F, Mittler J, Mizuno T, Torzilli G, Ulrich A, Vauthey JN.

Visc Med. 2017 Mar;33(1):76-81. doi: 10.1159/000463468. Epub 2017 Feb 28. No abstract available.

14.

Arguments for and against Centralization in Oncologic Visceral Medicine.

Keck Chair T, Herrlinger Chair KR, Faiss S, Lordick F, Mansky T, Welsch T.

Visc Med. 2017 May;33(2):148-152. doi: 10.1159/000467970. Epub 2017 Mar 30. No abstract available.

PMID:
28560231
15.

Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial.

Huhn S, Weinhold N, Nickel J, Pritsch M, Hielscher T, Hummel M, Bertsch U, Huegle-Doerr B, Vogel M, Angermund R, Hänel M, Salwender HJ, Weisel K, Dürig J, Görner M, Kirchner H, Peter N, Graeven U, Lordick F, Hoffmann M, Reimer P, Blau IW, Jauch A, Dembowsky K, Möhler T, Wuchter P, Goldschmidt H.

Bone Marrow Transplant. 2017 Aug;52(8):1194-1198. doi: 10.1038/bmt.2017.91. Epub 2017 May 15. No abstract available.

16.

Management of Metastatic Gastric Cancer.

Obermannová R, Lordick F.

Hematol Oncol Clin North Am. 2017 Jun;31(3):469-483. doi: 10.1016/j.hoc.2017.01.006. Epub 2017 Mar 22. Review.

PMID:
28501088
17.

3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer.

Lutz MP, Zalcberg JR, Ducreux M, Aust D, Bruno MJ, Büchler MW, Delpero JR, Gloor B, Glynne-Jones R, Hartwig W, Huguet F, Laurent-Puig P, Lordick F, Maisonneuve P, Mayerle J, Martignoni M, Neoptolemos J, Rhim AD, Schmied BM, Seufferlein T, Werner J, van Laethem JL, Otto F.

Eur J Cancer. 2017 Jul;79:41-49. doi: 10.1016/j.ejca.2017.03.022. Epub 2017 Apr 29.

18.

What treatment in 2017 for inoperable pancreatic cancers?

Taieb J, Pointet AL, Van Laethem JL, Laquente B, Pernot S, Lordick F, Reni M.

Ann Oncol. 2017 Jul 1;28(7):1473-1483. doi: 10.1093/annonc/mdx174.

PMID:
28459988
19.

Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study.

Cella CA, Di Minno G, Carlomagno C, Arcopinto M, Cerbone AM, Matano E, Tufano A, Lordick F, De Simone B, Muehlberg KS, Bruzzese D, Attademo L, Arturo C, Sodano M, Moretto R, La Fata E, De Placido S.

Oncologist. 2017 May;22(5):601-608. doi: 10.1634/theoncologist.2016-0246. Epub 2017 Apr 19.

PMID:
28424324
20.

Salvage chemotherapy for advanced gastric cancer: more than a false hope?

Lordick F.

Lancet Gastroenterol Hepatol. 2017 Apr;2(4):240-241. doi: 10.1016/S2468-1253(17)30006-7. Epub 2017 Jan 19. No abstract available.

PMID:
28404143

Supplemental Content

Loading ...
Support Center